Skip to main content

Advertisement

Log in

Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?

  • Editorial
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Mills GH (2007) Hydroxyethyl starch: does our choice of colloid prevent or add to renal impairment? Br J Anaesth 98:157–159

    Article  PubMed  CAS  Google Scholar 

  2. Moran SM, Myers BD (1985) Pathophysiology of protracted acute renal failure in man. J Clin Invest 76:1440–1448

    Article  PubMed  CAS  Google Scholar 

  3. Wadhausen P, Kiesewetter H, Leipniz G et al (1991) Hydroxyethyl starch-induced transient renal failure in pre-existing glomerular damage. Acta Med Austriaca 18:52–55

    Google Scholar 

  4. Hussain SF, Dew PJ (1989) Acute renal failure after infusion of gelatins. BMJ 299:1137–1138

    Article  PubMed  CAS  Google Scholar 

  5. Rozich JD, Paul RV (1989) Acute renal failure precipitated by elevated colloids osmotic pressure. Am J Med 87:359–360

    Article  PubMed  CAS  Google Scholar 

  6. Shortgen F, Girou E, Deye N, Brochard L (2008) The risk associated with hyperoncotic colloids in patients with shock. Intensive Care Med. doi: 10.1007/s00134–008-1225-2

  7. Boer WH, Koomans HA, Dorhout Mees EJ (1987) Renal haemodynamics and sodium handling after hyperoncotic albumin infusion in sodium-restricted normal man. Eur J Clin Invest 17:442–447

    Article  PubMed  CAS  Google Scholar 

  8. Baron JF (2000) Pharmacology of crytalloids and colloids. In: NATA (ed.) Transfusion medicine and alternative to blood transfusion. R&J-Editions Médicales, Paris, pp 123–137

  9. Moretti EW, Robertson KM, Gan TJ (2003) The colloid crystalloid debate: are we asking the right question? TATM 5:378–391

    Google Scholar 

  10. De Labarthe A, Jacobs F, Blot F (2001) Acute renal failure secondary to hydroxyethyl starch administration in a surgical patient. Am J Med 111:417–418

    Article  PubMed  Google Scholar 

  11. Honoré PM, Jacquet LM, Beale R, Renauld JC, Valadi D, Noirhomme P, Goenen M (2001) Effects of normothermia versus hypothermia on extravascular lung water and serum cytokines during cardiopulmonary bypass: a randomized, controlled trial. Crit Care Med 29:1903–1909

    Article  PubMed  Google Scholar 

  12. Moran M, Kasper C (1987) Acute renal failure associated with elevated plasma oncotic pressure. N Engl J Med 317:150–153

    PubMed  CAS  Google Scholar 

  13. Jungheinrich C, Scharpf R, Wargenau M, Bepperling F, Baron JF (2002) The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 95:551–554

    Article  Google Scholar 

  14. Shortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, Brochard L (2001) Effects of hydroxyethylstarch and gelatine on renal function in severe sepsis: a multicentre randomised study. Lancet 357:911–916

    Article  Google Scholar 

  15. Bernal W, Wendon J (2001) Comparison of patients with paracetamol-induced hepatotoxic effects receiving human albumin solution or hydroxyethyl starch. Lancet 358:583–584

    Article  Google Scholar 

  16. Vincent J-L (2007) Fluid resuscitation: colloids versus crystalloids. Acta Clin Belg 62:408–411

    Google Scholar 

  17. Kheterpal S, Tremper KK, Englesbe MJ, O’Reilly M, Shanks AM, Fetterman DM, Rosenberg AL, Swartz RD (2007) Predictors of postoperative acute renal failure after non cardiac surgery in patients with previously normal renal function. Anesthesiology 107:892–902

    Article  PubMed  Google Scholar 

  18. Chacko B, John GT, Balakrishnan N, Kirubakaran MG, Jacob CK (2006) Osmotic nephropathy resulting from maltose-based intravenous immunoglobulin therapy. Ren Fail 28:193–195

    Article  PubMed  Google Scholar 

  19. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German competence network sepsis (SepNet) (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125–139

    Article  PubMed  CAS  Google Scholar 

  20. Muller L, Jaber S, Lefrant J-Y (2008) Insuline and pentastarch for severe sepsis. N Engl J Med 358:2072–2073

    PubMed  CAS  Google Scholar 

  21. Sakr Y, Payen D, Reinhart K, Sipmann FS, Zavala E, Bewley J, Marx G, Vincent JL (2007) Effects of hydroxyethyl starch administration on renal function in critically ill patients. Br J Anaesth 98:216–224

    Article  PubMed  CAS  Google Scholar 

  22. Brunkhorst FM, Shortgen F (2007) Effects of hydroxyethyl starch in critically ill patients. Br J Anaesth 98:842–843

    Article  PubMed  CAS  Google Scholar 

  23. Mahmood A, Gosling P, Vohra RK (2007) Randomized clinical trial comparing the effects on renal function of hydroxylethyl starch or gelatin during aortic aneurysm surgery. Br J Surg 94:427–433

    Article  PubMed  CAS  Google Scholar 

  24. Available from http://www.clinicaltrials.org. Last accessed on 4 July 2008

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Patrick M. Honore.

Additional information

This editorial refers to the article available at: doi:10.1007/s00134-008-1225-2.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Honore, P.M., Joannes-Boyau, O. & Boer, W. Hyperoncotic colloids in shock and risk of renal injury: enough evidence for a banning order?. Intensive Care Med 34, 2127–2129 (2008). https://doi.org/10.1007/s00134-008-1226-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-008-1226-1

Navigation